Category: 5. Health
-
Ultra-sensitive robotic ‘finger’ can take patient pulses, check for lumps
Researchers at the University of Science and Technology of China have developed a soft robotic “finger” with a sophisticated sense of touch that can perform routine doctor office examinations, including taking a patient’s pulse and checking for abnormal lumps. This work was published October 9… Continue Reading
-
Dual immunotherapy plus chemotherapy benefits specific subset of patients with lung cancer
Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that patients with metastatic non-squamous non-small cell lung cancer (NSCLC) harboring specific mutations in the STK11 and/or KEAP1 tumor suppressor genes were more likely to benefit from adding the… Continue Reading
-
Study uncovers mutations and DNA structures driving bladder cancer
How bladder cancer originates and progresses has been illuminated as never before in a study led by researchers at Weill Cornell Medicine and the New York Genome Center. The researchers found that antiviral enzymes that mutate the DNA of normal and cancer cells are key promoters of early bladder… Continue Reading
-
Amazon Opening 20 New Pharmacies In U.S. Expansion Of Same Day Delivery
Amazon will more than double to 20 the number of cities where its customers can get same day … [+] delivery of their prescriptions by opening new pharmacies in these markets. Amazon Pharmacy Amazon will more than double to 20 the number of cities where its customers can get same day delivery of… Continue Reading
-
Off-brand Ozempic, Zepbound and other weight loss products carry undisclosed risks for consumers
In just a few years, brand-name injectable drugs such as Ozempic, Wegovy, Mounjaro and Zepbound have rocketed to fame as billion-dollar annual sellers for weight loss as well as to control blood sugar levels and reduce the risk of heart disease. But the price of these injections is steep:… Continue Reading
-
DEA could reclassify marijuana to a less restrictive category – a drug policy expert weighs the pros and cons
The Drug Enforcement Administration announced in early 2024 that it would act on President Joe Biden’s call to reclassify marijuana, moving it from the tightly controlled Schedule I category that it has been in since 1970 to the less restrictive Schedule III status of the Controlled… Continue Reading
-
Cell Therapy “Very Promising” For Cancer, Parkinson’s, More
Senior Investigator Shinya Yamanaka poses for a portrait in the Yamanaka Lab at Gladstone … [+] Institutes. GLADSTONE INSTITUTES Seventeen years ago, the world woke up to an astounding scientific breakthrough: a team of Japanese scientists, led by Shinya Yamanaka, had reprogrammed skin cells to… Continue Reading
-
Not Many Employers Cover GLP-1 Weight Loss Drugs
Despite the boom in popularity of expensive GLP-1 drugs to treat weight loss, fewer than one in … [+] five large employers are covering such prescriptions, a new KFF analysis shows. In this photo is Ozempic, a GLP-1 for adults with type 2 diabetes that along with diet and exercise may improve… Continue Reading
-
In a warming world, public needs to know more about protections from mosquito-borne illnesses
The hospitalization last summer of Dr. Anthony Fauci, former head of the National Institute of Allergy and Infectious Diseases, with West Nile virus — and his account of it this week in the New York Times — have helped raise public awareness of the dangers of mosquito borne-illness, which can… Continue Reading
-
Will AI tools revolutionize public health? Not if they continue following old patterns, researchers argue
As tools powered by artificial intelligence increasingly make their way into health care, the latest research from UC Santa Cruz Politics Department doctoral candidate Lucia Vitale takes stock of the current landscape of promises and anxieties. Proponents of AI envision the technology helping to… Continue Reading